A Phase 3, Double-Blind, Double-Dummy, Multi-Center, prospective, Randomized Study of the Efficacy and Safety of LCP-Tacro Tablets, Once Daily, compared to Prograf Capsules, Twice daily, in Combination with Mycophenolate Mofetil for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients.
A Three-Part, Multi-Centre, Randomised, Double Blind, Placebo-Controlled, Parallel-Group, Sequential Adaptive, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of OPN305, a Humanised Monoclonal Antibody that Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function.
Efficacy and Safety of Alefacept in Combination with Tacrolimus, Mycophenolate Mofetil and Steroids in De-Novo Kidney Transplantation – a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parellel Group Study.
A Long-Term Follow Up Study to Evaluate the Safety and Efficacy in Transplant Recipients Treated with Modified Release Tacrolimus, FK506E (MR4), Based Immunosuppression Regimen.
VICTOR Study – (MT17973) Valcyte in CMV-disease treatment of solid organ recipients
Open Randomized Study to Evaluate Efficacy and safety of Oral Valgancyclovir Versus IV Ganciclovir for the Treatment of CMV Disease in Solid Organ Transplant Recipients
A Multicentre, Randomised, Double-blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Different Concentrations of FK778 with Tacrolimus (FK506) and Steroids versus a Standard Regimen of Tacrolimus, MMF and Steroids in Renal Transplant Patients.
Najważniejsze publikacje naukowe (66 KB)